American Morning

Tune in at 6am Eastern for all the news you need to start your day.
July 13th, 2010
09:47 AM ET

FDA Avandia hearings panel decides fate of diabetes drug

An FDA panel is will begin hearings on Avandia today. The drug that's safety has been questioned since 2007 and could be pulled from the market. Steven Nissen has authored a study finding it could increase the risk of heart attacks. He spoke to CNN's Kiran Chetry Tuesday.

Filed under: Health
soundoff (One Response)
  1. Barbara

    Other drugs have been pulled for links with cardiovascular events- why not avandia? I would not want to take it, even if prescribed by a board certified endocrinologist. There are plenty of other options.

    July 15, 2010 at 6:36 am |